Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.21.2
Shareholders' Deficit (Details) - Schedule of warrant activities - Warrant [Member]
9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]  
Number of Warrants, Balance Outstanding, Beginning 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning (in Dollars per share) | $ / shares $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 3 years 7 months 28 days
Aggregate Intrinsic Value, Balance Outstanding, Beginning (in Dollars) | $ $ 137,000
Number of Warrants, Exercised (1,050,000)
Weighted Average Exercise Price, Exercised (in Dollars per share) | $ / shares $ 0.01
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised
Number of Warrants, Cancelled
Weighted Average Exercise Price, Cancelled (in Dollars per share) | $ / shares
Weighted Average Remaining Contractual Term (Years), Cancelled
Aggregate Intrinsic Value, Cancelled
Number of Warrants, Balance Outstanding, Ending 1,000,000
Weighted Average Exercise Price, Balance Outstanding, Ending (in Dollars per share) | $ / shares $ 0.09
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 2 years 9 months 18 days
Number of Warrants, Exercisable 1,000,000
Weighted Average Exercise Price, Exercisable (in Dollars per share) | $ / shares $ 0.09
Weighted Average Remaining Contractual Term (Years), Exercisable 2 years 9 months 18 days